Changsheng Du,Chang Liu,Jiuhong Kang,Guixian Zhao,Zhiqiang Ye,Shichao Huang,Zhenxin Li,Zhiying Wu,Gang Pei

Abstract:Nat. Immunol. 10, 1252–1259 (2009); published online 18 October 2009; corrected after print 4 December 2009 In the version of this article initially published, the Actin loading control blot for the top blot is missing from Figure 5c. The error has been corrected in the HTML and PDF versions of the article.

Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

Corrigendum: MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy

Corrigendum to “miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus”

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Corrigendum: MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

Corrigendum: Immune Tolerance Induced by Hematopoietic Stem Cell Infusion after HLA Identical Sibling Kidney Transplantation

Corrigendum: MicroRNA-138-5p Suppresses Non-small Cell Lung Cancer Cells by Targeting PD-L1/PD-1 to Regulate Tumor Microenvironment

Erratum to “miR-223 Inhibits the Polarization and Recruitment of Macrophages via NLRP3/IL-1β Pathway to Meliorate Neuropathic Pain”

Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Erratum to: "Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p"

Corrigendum: A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis

Erratum to "Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway"

Corrigendum: Deep sequencing of plasma exosomal microRNA level in psoriasis vulgaris patients

Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review

Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy

Corrigendum to “Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment” [Bioact. Mater. 18C (2022) 1–14]

Corrigendum to “Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4” [Genes & Diseases 9(2022) 443-455]

Corrigendum: The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years

Corrigendum: TLR2 Expression in Peripheral CD4+ T Cells Promotes Th17 Response and Is Associated with Disease Aggravation of Hepatitis B Virus-Related Acute-On-Chronic Liver Failure